UBS (NYSE: UBS)
Represented UBS (NYSE: UBS) in its investment in the Series D Convertible Preferred Stock of Exact Laboratories, Inc., a developer of genomics-based technologies designed to eradicate certain cancers.
Represented UBS (NYSE: UBS) in its investment in the Series D Convertible Preferred Stock of Exact Laboratories, Inc., a developer of genomics-based technologies designed to eradicate certain cancers.